期刊文献+

中国肝癌肝移植临床实践指南(2014版) 被引量:5

下载PDF
导出
摘要 据统计,中国每年超过30万人死于肝细胞癌(肝癌),占全球肝癌死亡人数的一半左右。而肝移植被全世界认可为治疗终末期肝病的有效手段之一。自20世纪90年代掀起第二次肝移植热潮以来,我国肝移植事业发展迅猛,呈专业化和规模化态势,在移植数量和质量方面已接近或达到西方发达国家水平。截至2014年4月,中国肝移植注册网站登记肝移植26751例。目前,肝移植在全国范围内已得到广泛开展,亟待相关临床实践指南来指导全国肝移植工作更规范、安全、有效地开展。
出处 《实用器官移植电子杂志》 2015年第2期66-71,共6页 Practical Journal of Organ Transplantation(Electronic Version)
  • 相关文献

参考文献22

  • 1Anjana A Pillai,Josh Levitsky.Overview of immunosuppression in liver transplantation[J].World Journal of Gastroenterology,2009,15(34):4225-4233. 被引量:22
  • 2张照辉,马力文,宋世兵,修典荣,王俊杰,杨晓霞,贾易木.肝癌肝移植术后辅助化疗的临床分析[J].中华肿瘤杂志,2005,27(1):45-47. 被引量:15
  • 3Jian Yong Lei,Wen Tao Wang,Lu Nan Yan.Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience[J]. European Journal of Gastroenterology & Hepatology . 2014 (2)
  • 4Roberto Galuppo,Angie McCall,Roberto Gedaly,Daisuke Morioka.The Role of Bridging Therapy in Hepatocellular Carcinoma[J]. International Journal of Hepatology . 2013
  • 5Carlo Sposito,Luigi Mariani,Alessandro Germini,Maria Flores Reyes,Marco Bongini,Glenda Grossi,Sherrie Bhoori,Vincenzo Mazzaferro.Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study<!-- Doctopic: TAS -->[J]. Journal of Hepatology . 2013 (1)
  • 6Abhijeet Waghray,Bengi Balci,Galal El‐Gazzaz,Richard Kim,Robert Pelley,KV Narayanan Menon,Bassam Estfan,Carlos Romero‐Marrero,Federico Aucejo.Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation[J]. Clin Transplant . 2013 (4)
  • 7Gang Huang,Eric C. H. Lai,Wan Yee Lau,Wei-ping Zhou,Feng Shen,Ze-ya Pan,Si-yuan Fu,Meng-chao Wu.Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels[J]. Annals of Surgery . 2013 (3)
  • 8K. V. Menon,A. R. Hakeem,N. D. Heaton.Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma[J]. Aliment Pharmacol Ther . 2012 (4)
  • 9Ivan Tjong-a-Hung.Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study[J]. OncoTargets and Therapy . 2012 (default)
  • 10R.M. Martín-Mateos,J. Graus,A. Albillos,C. Arocena,M.A. Rodríguez Gandía,C. Blesa,F. García-Hoz,M. García González,F.J. García-Alonso,R. Bárcena.Initial Immunosuppression With or Without Basiliximab: A Comparative Study[J]. Transplantation Proceedings . 2012 (9)

二级参考文献121

  • 1Waki K.UNOS Liver Registry:ten year survivals.Clin Transpl 2006; 29-39.
  • 2Groth CG.Forty years of liver transplantation:personal recollections.Transplant Proc 2008; 40:1127-1129.
  • 3Murray G,Holden R.Transplantation of kidneys,experimentally and in human cases.Am J Surg 1954; 87:508-515.
  • 4Taylor AL,Watson CJ,Bradley JA.Immunosuppressive agents in solid organ transplantation:Mechanisms of action and therapeutic efficacy.Crit Rev Oncol Hematol 2005; 56:23-46.
  • 5Borel JF,Feurer C,Gubler HU,Stahelin H.Biological effects of cyclosporin A:a new antilymphocytic agent.Agents Actions 1976; 6:468-475.
  • 6Kotru A,Sheperd R,Nadler M,Chapman W,Huddleston C,Lowell J.Combined lung and liver transplantation:the United States experience.Transplantation 2006; 82:144-145; author reply 145.
  • 7Rasmussen A,Davies HF,Jamieson NV,Evans DB,Calne RY.Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival.Transplantation 1995; 59:919-921.
  • 8Geissler EK,Schlitt HJ.Immunosuppression for liver transplantation.Gut 2009; 58:452-463.
  • 9Tisone G,Orlando G,Angelico M.Operational tolerance in clinical liver transplantation:emerging developments.Transpl Immunol 2007; 17:108-113.
  • 10Mazariegos GV,Reyes J,Marino IR,Demetris AJ,Flynn B,Irish W,McMichael J,Fung JJ,Starzl TE.Weaning of immunosuppression in liver transplant recipients.Transplantation 1997; 63:243-249.

共引文献120

同被引文献61

  • 1Peng Liu,Jia-Mei Yang,Wen-Yang Niu,Tong Kan,Feng Xie,Dian-Qi Li,Ye Wang,Yan-Ming Zhou,Department of Special Treatment and Liver Transplantation,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200438,China Peng Liu,Department of Hepatobiliary Surgery,Navy General Hospital,Beijing 100037,China.Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(9):1123-1128. 被引量:14
  • 2韩克起,顾伟,胡侠,张亚妮,黄雪强,刘岭,苏永华,凌昌全.小鼠肝癌原位移植模型的建立及生物学特性[J].中西医结合学报,2004,2(5):372-374. 被引量:23
  • 3张树民,曾昭冲,孙菁,程洁敏,汤钊猷.肝细胞肝癌肺转移的预后因素分析[J].实用肿瘤杂志,2005,20(5):395-400. 被引量:13
  • 4Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma [ J ]. Lancet, 2012, 379(9822): 1245-1255.
  • 5Wang F, Wang G, Liu T, et al. B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor pro- gression[J]. Cancer Invest, 2014, 32(6): 262-271.
  • 6Wan S, Kuo N, Kryczek I, et al. Myeloid cells in hepatocellular carcinoma [ J ]. Hepatology, 2015, 62 (4) : 1304-1312.
  • 7Sun J, Mao Y, Zhang YQ, et al. Clinical significance of the in- duction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer[ J ]. Oncol Lett, 2013, 6(5): 1253-1260.
  • 8Chen Jr, Chen CH, Ku KL, et al. Glycoprotein B7-H3 overexpres- sion and aberrant glycosylation in oral cancer and immune response [J]. Proc Natl Acad Sci USA, 2015, 112(42) : 13057-13062.
  • 9Sun TW, Gao Q, Qiu sJ, et al. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressive- ness and postoperative recurrence [ J ]. Cancer Immunol Immu- uother, 2012, 61(11): 2171-2182.
  • 10Kunisch E, Fuhrmann R, Roth A, et al. Macrophage specificity of three anti-CD68 monocloual antibodies ( KP1, EBMll, and PGM1) widely used for immunohistochemistry and flow cytometry [J~. Ann Rheum Dis, 2004, 63(7) : 774-784.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部